SNDX · TickerCove

SNDXSyndax Pharmaceuticals, Inc.Healthcare · Biotechnologyas of 2026-09-16

Horizon

Issued 2026-09-16 at $17.28 · now $17.28 (2026-09-16, +0.0% since)

Based on its own history, a month from the 2026-09-16 close, SNDX has typically landed between $13.85 and $21.85 — a range of −19.9% to +26.5% from the issuance price $17.28.

Range of outcomes in historically similar periods — not a price prediction. Ranges are scored publicly on /methodology.

Actual close
Typical path (median)
Middle 50% of outcomes
90% range

2,629 overlapping 1 month windows · 2016-03-02 – 2026-08-17 · basis climatology · forecast (batch). Probability up 53.9% (90% CI 51.7–56.1%, ≈1,408 obs).

The cone is anchored at the 2026-09-16 issuance close ($17.28) — the price the forecast resolves against on 2026-10-15, not the latest close. The drawn path shape is illustrative (bands widen with √t); every labeled number is real — the anchor, the scored batch p90/IQR endpoints, and the typical move.

52-week range$17.28 · 35% of range

$13.11 low$25.15 high

Trailing 52 weeks to 2026-09-16 — factual context, not a signal.

Base rate up · monthiClimatology base rate that a US-listed stock rises over a month, with its 90% CI and ≈1,408 effective observations. Not a call on this stock — we have no evidence its odds differ.

53.9%

90% CI 51.7%–56.1%

Distribution · month iiThe price-anchored range: typical move (median), and the p90 downside/upside — 90% of similar periods stayed inside these. Ranges, not a prediction of direction.

−1.1%

typical move · IQR 19.5%

−19.9%worst (p90)+26.5%best (p90)

Insider convictioniOpen-market common-stock purchases by company insiders in the last 90 days (grants and option exercises excluded). Historical tendency, not advice — detail below.

conviction buys

0 open-market sales

Congress disclosuresiRecent disclosed congressional trades for this company. Purchase clusters (≥2 members buying within 90 days) historically preceded a modestly higher forward return (+32 bp/mo in 2022–2026, +45 bp/mo in 2015–2021) — a descriptive tendency, not a forecast input. Detail below.

0 buys · 0 sells · 0 members

cluster tilt persisted, ~halved after 2021

Where SNDX has typically landed a month from the 2026-09-16 close of $17.28 — the range is history, not a prediction.

now $17.28 (+0.0%)
typical $17.08 (-1.1%)
middle 50% $15.4–$18.77
90% range $13.85–$21.85

Actual 1-month windows behind the coneiEvery overlapping 1-month window in this security's own price history was ranked by realized return; shown are the 3 worst and 3 best of 2,629 windows spanning 2016-03-02 to 2026-09-16. Not cherry-picked — these are the extremes of the full sample. Max drop / max rise are the deepest and highest points reached within each window. See /methodology.

Start	Return	Max drop	Max rise
3 worst
2018-10-01	−43.5%	−45.2%	+0.0%
2018-09-28	−42.9%	−42.9%	+4.2%
2021-03-23	−42.1%	−45.3%	+2.7%
3 best
2020-04-03	+105.4%	+0.0%	+109.2%
2020-04-08	+102.1%	+0.0%	+104.6%
2020-04-21	+97.7%	+0.0%	+102.3%

2,629 overlapping windows · 2016-03-02 – 2026-09-16 · not cherry-picked

Seasonality · by month i

iFor each calendar month, the share of years this security closed higher than the month before, and the average month-over-month return, over ~11 years of its own price history. Cells are shaded by average return. This is historical frequency, not a prediction — no month is a signal.

Jan

60%

+3.9%

n=10

Feb

70%

+8.0%

n=10

Mar

60%

+5.4%

n=10

Apr

36%

+0.6%

n=11

May

36%

−2.6%

n=11

Jun

55%

+0.7%

n=11

Jul

55%

+0.3%

n=11

Aug

64%

+9.8%

n=11

Sep

45%

−3.8%

n=11

Oct

20%

−7.8%

n=10

Nov

60%

+4.6%

n=10

Dec

50%

+3.6%

n=10

Up-frequency and average month-over-month return · historical frequency, not a prediction

Reported insider & political trades

Every Form 4 the people closest to this company have filed with the SEC — plotted against the share price, aggregated by month, and shown with the gap between when each trade happened and when it was disclosed. A public record, not advice.

Date	Person	Role	Action	Shares @ price	Value	Ownership Δ	vs S&P 1m	vs S&P 6m	Owned after	Filing
2026-07-08	Metzger Michael A	director	Sale	32,375 @ $24.24	$785K	−6.3% of holding	−22.7%	not yet — horizon still open	484,843	Form 4 · filed 1 day after the trade
2026-06-12	Botwood Nicholas A.J.	officer	Sale	31,235 @ $18.14	$567K	−33.9% of holding	+26.9%	not yet — horizon still open	60,885	Form 4 · filed same day
2026-06-11	Botwood Nicholas A.J.	officer	Sale	34,280 @ $18.00	$617K	−36.0% of holding	+32.6%	not yet — horizon still open	60,885	Form 4 · filed 1 day after the trade
2026-06-01	Metzger Michael A	director	Sale	6,847 @ $18.99	$130K	−1.4% of holding	+12.3%	not yet — horizon still open	484,843	Form 4 · filed 1 day after the trade
2026-06-01	Goldan Keith A.	director	Sale	1,177 @ $18.99	$22K	−0.8% of holding	+12.3%	not yet — horizon still open	139,252	Form 4 · filed 1 day after the trade
2026-02-09	Metzger Michael A	director	Sale	17,159 @ $21.03	$361K	−3.4% of holding	+17.9%	−15.9%	491,690	Form 4 · filed 1 day after the trade
2026-02-09	Goldan Keith A.	director	Sale	3,410 @ $21.03	$72K	−2.4% of holding	+17.9%	−15.9%	140,429	Form 4 · filed 1 day after the trade
2026-02-06	Metzger Michael A	director	Sale	7,412 @ $20.62	$153K	−1.4% of holding	+16.9%	−15.6%	508,849	Form 4 · filed same day
2026-02-06	Goldan Keith A.	director	Sale	2,082 @ $20.62	$43K	−1.4% of holding	+16.9%	−15.6%	143,839	Form 4 · filed same day
2025-09-08	Metzger Michael A	director	Sale	157,307 @ $16.41	$2.6M	−34.5% of holding	−2.7%	+43.0%	298,661	Form 4 · filed same day
2025-08-18	Podlesak Dennis	director	Sale	19,200 @ $15.84	$304K	−9.1% of holding	−9.5%	+20.3%	191,763	Form 4 · filed same day
2025-08-15	Podlesak Dennis	director	Sale	19,200 @ $15.54	$298K	−9.1% of holding	−7.0%	+22.5%	191,763	Form 4 · filed 3 days after the trade
2025-08-14	Podlesak Dennis	director	Sale	19,200 @ $14.19	$273K	−9.1% of holding	+5.1%	+32.7%	191,763	Form 4 · filed 4 days after the trade
2025-07-16	Metzger Michael A	director	Sale	7,534 @ $9.29	$70K	−2.5% of holding	+55.9%	+120.6%	298,661	Form 4 · filed 2 days after the trade
2025-07-16	Goldan Keith A.	director	Sale	1,296 @ $9.29	$12K	−1.4% of holding	+55.9%	+120.6%	92,450	Form 4 · filed 2 days after the trade
2025-05-19	Katkin Keith	director	Purchase	10,000 @ $9.11	$91K	+11.1% of holding	+3.8%	+72.2%	100,000	Form 4 · filed same day
2025-05-19	Huber Martin H. Jr.	director	Purchase	5,000 @ $8.99	$45K	+6.8% of holding	+3.8%	+72.2%	79,000	Form 4 · filed same day
2025-05-19	Goldan Keith A.	director	Purchase	3,000	—	+3.3% of holding	+3.8%	+72.2%	93,746	Form 4 · filed same day
2025-05-19	Goldan Keith A.	director	Purchase	3,000	—	+3.3% of holding	+3.8%	+72.2%	93,746	Form 4 · filed same day
2025-05-16	Botwood Nicholas A.J.	officer	Purchase	11,765 @ $8.99	$106K	+50.3% of holding	+6.0%	+69.9%	35,165	Form 4 · filed 3 days after the trade
2025-03-04	Metzger Michael A	director	Sale	7,814 @ $15.05	$118K	−2.5% of holding	−8.0%	−0.1%	300,121	Form 4 · filed 2 days after the trade
2025-02-10	Metzger Michael A	director	Sale	13,288 @ $15.50	$206K	−4.2% of holding	−5.7%	−21.2%	300,121	Form 4 · filed 2 days after the trade
2025-02-10	Gallagher Neil	director	Sale	4,618 @ $15.50	$72K	−5.1% of holding	−5.7%	−21.2%	85,095	Form 4 · filed 2 days after the trade
2025-02-10	Goldan Keith A.	director	Sale	3,777 @ $15.50	$59K	−4.0% of holding	−5.7%	−21.2%	90,746	Form 4 · filed 2 days after the trade

The vs-S&P columns are a labeled look-back on what the stock did after each filing, measured against the index over the same window. Descriptive history, not a claim about the person or a reason to trade.

53 award / exercise / gift records — not counted as purchases

Awards, option exercises, gifts and tax-withholding disposals are shown separately and never counted as open-market purchases or sales — they carry no conviction information.

Date	Person	Role	Action	Shares	Owned after	Filing
2026-07-08	Metzger Michael A	director	Option exercise	32,375	517,218	Form 4
2026-07-08	Metzger Michael A	director	Option exercise	32,375	0	Form 4
2026-06-12	Botwood Nicholas A.J.	officer	Option exercise	31,235	92,120	Form 4
2026-06-12	Botwood Nicholas A.J.	officer	Option exercise	31,235	0	Form 4
2026-06-11	Botwood Nicholas A.J.	officer	Option exercise	22,515	95,165	Form 4
2026-06-11	Botwood Nicholas A.J.	officer	Option exercise	22,515	0	Form 4
2026-02-04	Metzger Michael A	director	Award / grant	440,000	440,000	Form 4
2026-02-04	Botwood Nicholas A.J.	officer	Award / grant	144,700	144,700	Form 4
2026-02-04	Goldan Keith A.	director	Award / grant	118,000	118,000	Form 4
2026-02-04	Podlesak Dennis	director	Award / grant	48,000	239,763	Form 4
2026-02-04	Jarrett Jennifer	director	Award / grant	24,000	114,000	Form 4
2026-02-04	Legault Pierre	director	Award / grant	24,000	114,000	Form 4
2026-02-04	Goldan Keith A.	director	Award / grant	21,500	115,171	Form 4
2026-02-04	Goldan Keith A.	director	Award / grant	30,750	145,921	Form 4
2026-02-04	Rizo Aleksandra	director	Award / grant	24,000	49,000	Form 4
2026-02-04	Metzger Michael A	director	Award / grant	73,000	371,661	Form 4
2026-02-04	Metzger Michael A	director	Award / grant	144,600	516,261	Form 4
2026-02-04	Huber Martin H. Jr.	director	Award / grant	24,000	103,000	Form 4
2026-02-04	Botwood Nicholas A.J.	officer	Award / grant	24,000	59,165	Form 4
2026-02-04	Botwood Nicholas A.J.	officer	Award / grant	36,000	95,165	Form 4
2026-02-04	Katkin Keith	director	Award / grant	24,000	124,000	Form 4
2026-01-30	Goldan Keith A.	director	Other acquisition	1,219	93,671	Form 4
2025-12-01	Goldan Keith A.	director	Gift	1,224	92,452	Form 4
2025-09-08	Metzger Michael A	director	Option exercise	157,307	455,968	Form 4
2025-09-08	Metzger Michael A	director	Option exercise	157,307	0	Form 4
2025-08-18	Podlesak Dennis	director	Option exercise	19,200	210,963	Form 4
2025-08-18	Podlesak Dennis	director	Option exercise	19,200	0	Form 4
2025-08-15	Podlesak Dennis	director	Option exercise	19,200	210,963	Form 4
2025-08-15	Podlesak Dennis	director	Option exercise	4,800	0	Form 4
2025-08-15	Podlesak Dennis	director	Option exercise	14,400	0	Form 4
2025-08-14	Podlesak Dennis	director	Option exercise	19,200	210,963	Form 4
2025-08-14	Podlesak Dennis	director	Option exercise	19,200	0	Form 4
2025-07-31	Goldan Keith A.	director	Other acquisition	1,226	93,676	Form 4
2025-03-14	Metzger Michael A	director	Option exercise	6,074	306,195	Form 4
2025-03-14	Metzger Michael A	director	Option exercise	6,074	0	Form 4
2025-03-04	Metzger Michael A	director	Option exercise	7,814	307,935	Form 4
2025-03-04	Metzger Michael A	director	Option exercise	7,814	0	Form 4
2025-02-05	Metzger Michael A	director	Award / grant	364,000	364,000	Form 4
2025-02-05	Goldan Keith A.	director	Award / grant	110,500	110,500	Form 4
2025-02-05	Gallagher Neil	director	Award / grant	110,500	110,500	Form 4

Source: SEC Form 4 filings. Each row links to its original filing.

Across 2012–2021, stocks where a CEO, C-suite officer, or director had recently made an open-market common-stock purchase ran about +28 bp per month above the universe average (n=34,268 stock-weeks). A historical tendency, not a prediction.

Congressional disclosures

No congressional trades disclosed for this company.

Resolves in i

28d remaining

2026-09-173% elapsed2026-10-15

Logged immutably 2026-09-17; scored automatically on 2026-10-15 — no edits, ever.

Earnings & context analysis

These panels are being prepared. They are generated by multiple language models, checked, and stored before display — never written live for a page view. Until a model panel has been generated and reviewed for a company, nothing is shown here, honestly, rather than a placeholder.

Calibration i

Every forecast is logged when made and scored when the month is up. The record is shown from the day it starts — young and honest.

How scoring works →

Research tool, not investment advice — historical frequencies, not recommendations. A product of Marovel Technologies LLC. Full terms.

Seasonality · by month iHow this security has tended to do in each calendar month historically — a frequency, never a prediction.

Reported insider & political trades

Congressional disclosures

Seasonality · by month i